Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ryan Nelson

Executive Editor

Washington, D.C.
Ryan Nelson is managing editor of Informa’s Rose Sheet and the head of its cosmetics content channel, with particular expertise in evolving regulatory and legal issues. He’s been covering FDA-regulated industries for going on 15 years, previously reporting for the Gray Sheet (now Medtech Insight) where he handled beats including Capitol Hill and Emerging Technology. He began his career teaching English Literature to 9th grade boys at a private boarding school in Chattanooga, Tennessee, a role he misses only occasionally. Ryan is based in Informa’s Washington, D.C. office.

Latest From Ryan Nelson

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

Europe Regulation

Firmenich Certifies Global Operations To Fair Wage Standards, Sets Eye On Larger Value Chain

Firmenich says it is first in the industry and second in the world to certify 100% of employees to Fair Wage Network’s living wage standards. The Swiss fragrance and flavor firm is focused now on driving progress from suppliers and customers.

Business Strategies Ingredients

PCPC ‘Cautiously Optimistic’ About Cosmetics Reform Bill Moving Through Senate

The Modernization of Cosmetics Regulation Act, part of must-pass FDA user-fee legislation, aligns with a number of the Personal Care Products Council’s key principles for federal cosmetics reform. Preemption provisions could be stronger, but the bipartisan bill represents “a pivotal moment,” the trade association says.

Cosmetics Legislation

E.l.f. Cosmetics Gets Serious About Skin Care With New Product Launches, Awareness Campaign

E.l.f. Skin, now the fourth brand in the firm’s portfolio alongside e.l.f. Beauty, W3ll People, and Keys Soulcare, includes new Blemish Breakthrough and Pure Skin lines of clean, kind products priced at $14 or less.

Cosmetics Launches

Making Cosmetics Reform Beneficial For All; Former FDA Cosmetics Director Yearns For ‘Serious Sit-Down’

Federal legislative reform is an historic opportunity not only to strengthen the US FDA’s oversight of the cosmetics sector, but also to modernize the industry and its value proposition to consumers. John Bailey, independent advisor for cosmetics and colors at EAS Consulting Group, is confident there’s a way to do all, but "serious" stakeholder negotiations are needed.

Cosmetics Legislation

Cosmetics Industry Stakeholders Not Thrilled About Senate Reform Bill, And Why Should They Be?

In HBW Insight’s conversations with industry advocates about legislation in the US Senate to reform US cosmetics regulations, frustrations with the process have been palpable. Stakeholders suggest that science and proportionality are taking back seats to politics and that concerns about costs to industry, which ultimately could be passed on to consumers, are not being taken seriously enough.

Cosmetics Legislation
See All
UsernamePublicRestriction

Register